Abstract
Whether invasive lobular carcinoma of the breast per se constitutes a prognostically favorable type has been debated. The present series comprises 301 consecutive “classic” lobular breast carcinomas seen at one institution between 1994 and 2001, compared to an equal number of invasive ductal carcinomas at the same institution during the same period, matched for year of surgery, age, menopausal status, primary tumor size, nodal involvement, hormone receptor status and where possible histological grade. Despite matching, the lobular carcinomas were more frequently multifocal, had more involved nodes, lower grade and lower proliferative fraction. There was no significant difference in disease-free or overall survival, locoregional relapse or time to distant metastasis between the lobular and ductal groups overall or within any examined subset, though the lobular group showed a trend to earlier appearance of contralateral breast cancer. Classical lobular histology is not an independent factor in the prognosis of early breast cancer.
References
Fisher ER, Gregorio RM, Fisher B et al (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no 4). Cancer 36:1–85. doi :10.1002/1097-0142(197507)36:1<1::AID-CNCR2820360102>3.0.CO;2-4
Ellis IO, Galea M, Broughton N et al (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20:479–489
Martinez V, Azzopardi JG (1979) Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 3:467–488. doi:10.1111/j.1365-2559.1979.tb03029.x
du Toit RS, Locker AP, Ellis IO et al (1991) An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol 17:251–257
Cristofanilli M, Gonzalez-Angulo A, Sneige N et al (2005) Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 23:41–48. doi:10.1200/JCO.2005.03.111
Dian D, Herold H, Mylonas I et al (2008) Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Arch Gynecol Obstet. doi:10.1007/s00404-008-0662-z
Toikkanen S, Pylkkanen L, Joensuu H (1997) Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 76:1234–1240
Silverstein MJ, Lewinsky BS, Waisman JR et al (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73:1673–1677. doi :10.1002/1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B
Casolo P, Raspadori A, Drei B et al (1997) Natural history of breast cancer: lobular carcinoma versus ductal carcinoma in our experience. Ann Ital Chir 68:43–47
Fondrinier E, Guerin O, Lorimier G (1997) A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients). Bull Cancer 84:1101–1107
Winchester DJ, Chang HR, Graves TA et al (1998) A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 186:416–422. doi:10.1016/S1072-7515(98)00051-9
Mersin H, Yildirim E, Gulben K et al (2003) Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 29:390–395. doi:10.1053/ejso.2002.1423
Arpino G, Bardou VJ, Clark GM et al (2004) Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 6:R149–R156. doi:10.1186/bcr767
Santiago RJ, Harris EE, Qin L et al (2005) Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Cancer 103:2447–2454. doi:10.1002/cncr.21071
Gonzalez-Angulo AM, Sahin A, Krishnamurthy S et al (2006) Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin Breast Cancer 7:396–400
Tubiana-Hulin M, Stevens D, Lasry S et al (2006) Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol 17:1228–1233. doi:10.1093/annonc/mdl114
Ni MJ, Curran C, Hennessy E et al (2008) Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma. Br J Surg. doi:10.1002/bjs.6042
Molland JG, Donnellan M, Janu NC et al (2004) Infiltrating lobular carcinoma—a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast 13:389–396. doi:10.1016/j.breast.2004.03.004
Jayasinghe UW, Bilous AM, Boyages J (2007) Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Breast J 13:479–485. doi:10.1111/j.1524-4741.2007.00468.x
Pestalozzi BC, Zahrieh D, Mallon E et al (2008) Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 international breast cancer study group clinical trials. J Clin Oncol. doi:10.1200/JCO.2007.14.9336
Rakha EA, El-Sayed ME, Powe DG et al (2008) Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 44:73–83. doi:10.1016/j.ejca.2007.10.009
Sinha PS, Bendall S, Bates T (2000) Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers? Eur J Surg Oncol 26:733–737. doi:10.1053/ejso.2000.0994
Borst MJ, Ingold JA (1993) Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114:637–641
Orvieto E, Maiorano E, Bottiglieri L et al (2008) Clinico-pathological characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer (in press)
Lehr HA, Hansen DA, Kussick S et al (1999) Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol 30:1314–1320. doi:10.1016/S0046-8177(99)90062-X
Thor AD, Liu S, Moore DH et al (1999) Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 17:470–477
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Viale, G., Rotmensz, N., Maisonneuve, P. et al. Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat 117, 211–214 (2009). https://doi.org/10.1007/s10549-008-0112-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0112-4